Skip to content
Search

Latest Stories

Pharmacy leaders warn ministers about post-Brexit medicines shortages in Northern Ireland

A pharmacy stakeholder group has expressed concerns about shortages of medicines in Northern Ireland in the event of a ‘no-deal’ Brexit.

The UK Community Pharmacy Falsified Medicine Directive Working Group has called on the government to protect the supply of medicines into Northern Ireland following the end of the Brexit transition period on December 31.


Under the Northern Ireland protocol, the country will be obliged to align with the EU regulations including FMD, complicating routes of supply of medicines from the rest of the UK where those rules won't apply.

“If it becomes unviable for manufacturers and wholesalers to put stock into Northern Ireland, pharmacies in NI might quickly find themselves short of supplies and unable to service patients’ needs, said Raj Patel, chair of the UK Community Pharmacy FMD Working Group.

"Since medicines regulation is not a devolved responsibility, we are asking the Westminster government to clarify what arrangements it has for medicine verification in Northern Ireland after December 31.”

Last month, the Association of the British Pharmaceutical Industry warned a parliamentary committee that the medicines supply route across the Irish Sea could face disruption.

The UK Community Pharmacy FMD Working Group consists of the national organisations representing community pharmacy across the UK.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less